Personalised Immunotherapy Platform

Clinical trial NCT06536257 · RECRUITING

Trial details

NCT number: NCT06536257
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Cutaneous Squamous Cell Carcinoma Basal Cell Carcinoma Merkel Cell Carcinoma Solid Tumor

Start date: 2021-06-08
Primary completion: 2027-06-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.